Explore DPP4/CD26/DPP-4 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
The DPP4 gene encodes dipeptidyl peptidase 4, which is identical to adenosine deaminase complexing protein-2, and to the T-cell activation antigen CD26. It is an intrinsic type II transmembrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. Dipeptidyl peptidase 4 is highly involved in glucose and insulin metabolism, as well as in immune regulation. This protein was shown to be a functional receptor for Middle East respiratory syndrome coronavirus (MERS-CoV), and protein modeling suggests that it may play a similar role with SARS-CoV-2, the virus responsible for COVID-19. [provided by RefSeq, Apr 2020]
| Target ID |
GM-T31391
|
| Target Name |
DPP4/CD26/DPP-4
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
1803
|
| Gene ID |
100061124 (Equus caballus), 13482 (Mus musculus), 1803 (Homo sapiens), 25253 (Rattus norvegicus) 281122 (Bos taurus), 478767 (Canis lupus familiaris), 493787 (Felis catus), 654491 (Macaca mulatta)
|
| Target Alternative Names |
ACT3,ADABP,ADCP-I,ADCP2,Adenosine deaminase complexing protein 2 (ADCP-2),CD26,Cd26,DPP-4,DPP4,DPPIV,Dipeptidyl peptidase 4,Dipeptidyl peptidase IV (DPP IV),Dpp-4,Dpp4,T-cell activation antigen CD26,THAM,TP103,WC10
|
| Uniprot Accession |
P28843,P27487,P14740,P81425,Q9N2I7
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target
|
| Disease |
Prostate Cancer, Ureteral obstruction, Diabetic Nephropathy
|
| Disease from KEGG |
Protein digestion and absorption
|
| Gene Ensembl |
ENSECAG00000017357, ENSMUSG00000035000, ENSG00000197635, ENSBTAG00000048246, ENSCAFG00845030056, ENSMMUG00000008387
|
| Target Classification |
Checkpoint-Immuno Oncology
|
Pre-made viral vector of DPP4/CD26/DPP-4 cDNA Clones/ORF Plasmid
DPP4/CD26/DPP-4 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo1803 | Pre-made Human DPP4/CD26/ADABP siRNA oligo Duplex | 1803 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo25253 | Pre-made Rat Dpp4/CD26/DPPIV siRNA oligo Duplex | 25253 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo13482 | Pre-made Mouse Dpp4/Cd26/THAM siRNA oligo Duplex | 13482 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo654491 | Pre-made Cynomolgus/Rhesus macaque DPP4 siRNA oligo Duplex | 654491 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo493787 | Pre-made Cat/Feline DPP4/CD26 siRNA oligo Duplex | 493787 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo478767 | Pre-made Dog/Canine DPP4 siRNA oligo Duplex | 478767 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo281122 | Pre-made Bovines/Cattle DPP4/ACT3/CD26 siRNA oligo Duplex | 281122 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100061124 | Pre-made Equine/Horse DPP4 siRNA oligo Duplex | 100061124 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
DPP4/CD26/DPP-4 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T31391-Ab | Human | Anti-Human DPP4/CD26/DPP-4 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody | Detail |
| GM-Tg-rg-T31391-Ab | Rat | Anti-Rat DPP4/CD26/DPP-4 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody | Detail |
| GM-Tg-mg-T31391-Ab | Mouse | Anti-Mouse DPP4/CD26/DPP-4 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody | Detail |
| GM-Tg-cynog-T31391-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque DPP4/CD26/DPP-4 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody | Detail |
| GM-Tg-felg-T31391-Ab | Cat/Feline | Anti-Cat/Feline DPP4/CD26/DPP-4 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody | Detail |
| GM-Tg-cang-T31391-Ab | Dog/Canine | Anti-Dog/Canine DPP4/CD26/DPP-4 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody | Detail |
| GM-Tg-bovg-T31391-Ab | Bovines/Cattle | Anti-Bovines/Cattle DPP4/CD26/DPP-4 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody | Detail |
| GM-Tg-equg-T31391-Ab | Equine/Horse | Anti-Equine/Horse DPP4/CD26/DPP-4 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody | Detail |
DPP4/CD26/DPP-4 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T31391-Ag | Human | Human DPP4/CD26/DPP-4 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T31391-Ag | Rat | Rat DPP4/CD26/DPP-4 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T31391-Ag | Mouse | Mouse DPP4/CD26/DPP-4 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T31391-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque DPP4/CD26/DPP-4 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T31391-Ag | Cat/Feline | Cat/Feline DPP4/CD26/DPP-4 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T31391-Ag | Dog/Canine | Dog/Canine DPP4/CD26/DPP-4 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T31391-Ag | Bovines/Cattle | Bovines/Cattle DPP4/CD26/DPP-4 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T31391-Ag | Equine/Horse | Equine/Horse DPP4/CD26/DPP-4 VLP (virus-like particle) | HEK293 | Products Developing |